Author Archives: admin


Stem Cell Clinic > Articles by: admin

Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery

By Stem Cell Medical Center

PUBLIC RELEASE DATE:

29-Jul-2014

Contact: Connie Hughes Connie.Hughes@wolterskluwer.com 646-674-6348 Wolters Kluwer Health

July 29, 2014 Advertising claims for cosmetic procedures using stem cells are running far ahead of the scientific evidence for safety and effectiveness, according to a review in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

"Stem cells offer tremendous potential, but the marketplace is saturated with unsubstantiated and sometimes fraudulent claims that may place patients at risk," write Dr Michael T. Longaker of Stanford University Medical Center and colleagues.

'Worrying advertisements' for cosmetic stem cell procedures

Dr Longaker and coauthors raise concerns about the unregulated use of stem cells for unproven indicationsincluding cosmetic procedures. While stem cell therapy "remains in its infancy," they write, "there are a growing number of cosmetic practitioners that are advertising minimally invasive, stem cell-based rejuvenation procedures."

The article was prompted by "worrying advertisements" claiming benefits of stem cell procedures for facelifts, breast augmentationeven "stem cell vaginal rejuvenation." These ads claim benefits from procedures that have not undergone rigorous scientific evaluationincluding potential risks related to stem cell and tissue processing and the effects of aging on stem cells.

To gain insight into these claims, Dr Longaker and coauthors performed a Google search for cosmetic stem cell treatments, the most common of which was "stem cell facelifts." Most procedures used "stem cells" isolated from fat. However, the websites provided little information on the quality of the stem cells used.

Without advanced cell-sorting procedures, these products used in these procedures likely contain many other types of cells besides fat-derived stem cells. Many clinics also offered plasma-rich platelet protein treatments, which they inaccurately marketed as stem cell therapy.

Read more from the original source:
Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery

Stem Cell Therapy, Stem Cell Research, Stem Cell Treatments

By Stem Cell Clinic

Welcome to the Silicon Valley Stem Cell Treatment Center, and affiliate of the California Stem Cell Treatment Center. At our state of the art clinic we are using cutting edge advanced techniques and the latest innovative technology to improve the health and well being of our patients. At Silicon Valley Stem Cell Treatment Center, we provide care for people suffering from diseases that may have limited treatment options and may respond to stem cell based regenerative treatment. The Silicon Valley Stem Cell Treatment Center emphasizes quality and our well trained physician is highly committed to clinical research and the advancement of regenerative medicine.

The California Stem Cell Treatment specialists who trained our physician, have been nationally recognized for working with autologous (your own) adipose derived stem cells providing investigational therapy to patients with various inflammatory and/or degenerative conditions. Our Centers utilize a fat transfer technology to isolate and implant the patient's own stem cells from a small quantity of fat harvested by liposuction on the same day. Using technology developed in South Korea, our group has developed an in office procedure to isolate this cellular medium called the Stromal Vascular Fraction or SVF which is very rich in stem cells. Our founders have also worked in conjunction with a number of international organizations and physicians of great expertise to help develop our protocols for procedures. In 2012, the Cell Surgical Network (CSN) was formed, of which we are an affiliate, to provide the same high level quality controlled investigational therapy nationwide and beyond. Under our IRB (Institutional Review Board) approved protocol, we in Silicon Valley are now also able to provide fat derived stem cell procedures on an investigational basis. Modeled after the California Stem Cell Treatment Center, we've formed a multidisciplinary team to evaluate patients with a variety of conditions often responsive to Stem Cell therapy. All affiliate members in the CSN, including our clinic will contribute to the California Centers IRB approved investigation. Patients who seek care at the Silicon Valley Stem Cell Treatment Center will be evaluated by one of our physicians and given our honest opinion as to the potential benefits and risks of stem cell therapy for their presenting condition.

California Stem Cell Treatment Center was founded in 2010 for the investigational use of stem cells procedures for degenerative conditions. California Stem Cell Treatment Center employs a clinical research coordinator to protect our valuable data, as our vision is to perfect our treatments and ultimately teach them to others.

Read the original post:
Stem Cell Therapy, Stem Cell Research, Stem Cell Treatments

Gift from Bacardi family will help Mayo Clinic researchers in Jacksonville close in on 'the future of medicine'

By Stem Cell Clinic

The future of medicine is regenerative medicine.

Thats a view shared by Thomas Gonwa, associate director of the Mayo Clinic Center for Regenerative Medicine in Jacksonville, and by Jorge and Leslie Bacardi.

Regenerative medicine will be the cutting-edge medicine of the 21st century, Gonwa says.

We think it is the most important thing happening in medicine, Leslie Bacardi said.

Now the Bacardis, who live in Nassau in the Bahamas, have given what Mayo Clinic officials call a substantial gift to fund ongoing research and clinical trials in regenerative medicine at the Mayo Clinic in Jacksonville.

Jorge Bacardi, part of the family that has been making rum and other spirits for 150 years, declined to specify the amount of the gift. Were not people who boast about the amount we give, he said.

Its an amount that should be sufficient to fund the ongoing research into regenerative medicine in Jacksonville, he said.

Doctors at the Mayo Clinic both in Jacksonville and in Rochester, Minn., now envision a future in which new organs can be grown for patients, using their own cells, and a time when the injection of stem cells can be used to repair a damaged organ.

Last year, Tim Nelson, a physician with the Center for Regenerative Medicine in Rochester, removed tissue from the arm of ABC Nightline reporter Bill Weir and created what Weir called a tiny piece of my cardiac tissue that had dramatically formed into the shape of a heart a pumping, three-dimensional glimpse into a future when this kind of cell could theoretically be injected into a heart-attack victim or a diseased child and literally mend the person from within.

That, to us, was just mind-boggling, Leslie Bacardi said. ... Regenerative medicine is for us an investment in our future and the future of medicine. It may take a while to reap any benefits, but when those benefits do come, it will make the investment seem small.

See the original post here:
Gift from Bacardi family will help Mayo Clinic researchers in Jacksonville close in on 'the future of medicine'

Stem cell discovery may make tissue regeneration more efficient

By Uncategorized

A new stem-cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts, according to UC San Francisco scientists who reported the findings in the current edition of Cell.

The work builds on a strategy that involves reprogramming adult cells back to an embryonic state in which they again have the potential to become any type of cell.

The efficiency of this process may soon increase thanks to the scientists identification of biochemical pathways that can inhibit the necessary reprogramming of gene activity in adult human cells. Removing these barriers increased the efficiency of stem-cell production, the researchers found.

Our new work has important implications for both regenerative medicine and cancer research, said Miguel Ramalho-Santos, Ph.D., associate professor of obstetrics, gynecology and reproductive sciences and a member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, who led the research, funded in part by a prestigious NIH Directors New Innovator Award.

The earlier discovery that it was possible to take specialized adult cells and reverse the developmental clock to strip the mature cells of their distinctive identities and characteristics and to make them immortal, reprogrammable cells that theoretically can be used to replace any tissue type led to a share of the Nobel Prize in Physiology or Medicine being awarded to UCSF, Gladstone Institutes and Kyoto University researcher Shinya Yamanaka, M.D., in 2012.

These induced pluripotent stem (iPS) cells are regarded as an alternative experimental approach to ongoing efforts to develop tissue from stem cells obtained from early-stage human embryos. However, despite the promise of iPS cells and the excitement surrounding iPS research, the percentage of adult cells successfully converted to iPS cells is typically low, and the resultant cells often retain traces of their earlier lives as specialized cells.

Researchers generate stem cells by forcing the activation within adult cells of pluripotency-inducing genes starting with the so-called Yamanaka factors a process that turns back the clock on cellular maturation.

Yet, as Ramalho-Santos notes, From the time of the discovery of iPS cells, it was appreciated that the specialized cells from which they are derived are not a blank slate. They express their own genes that may resist or counter reprogramming.

But the nature of what exactly was getting in the way of reprogramming remained poorly understood. Now, by genetically removing multiple barriers to reprogramming, we have found that the efficiency of generation of iPS cells can be greatly increased, he said. The discovery will contribute to accelerating the safe and efficient use of iPS cells and other reprogrammed cells, according to Ramalho-Santos.

Miguel Ramalho-Santos

More:
Stem cell discovery may make tissue regeneration more efficient

Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

By Uncategorized

Released: 29-Jul-2014 8:00 AM EDT Source Newsroom: Mayo Clinic Contact Information

Available for logged-in reporters only

Newswise JACKSONVILLE, Fla. Imagine a future in which a new lung is grown for a patient in need, using the patients own cellular material, or a day when an injection of replacement cells will enable a patient to self-heal damage in the brain, nerves or other tissues.

MULTIMEDIA ALERT: For audio and video of Dr. Keller and Jorge Bacardi talking about the gift and regenerative medicine, visit the Mayo Clinic News Network.

Regenerative medicine is no longer science fiction, and a substantial gift from Jorge and Leslie Bacardi of the Bahamas will significantly accelerate the research of Mayo Clinics Center for Regenerative Medicine on the Florida campus.

Jorge Bacardi, whose family has manufactured rum and other spirits for 150 years, suffered since childhood with primary ciliary dyskinesia, a debilitating lung disease that nearly ended his life. A double lung transplant at Mayos Florida campus in 2008 enabled him to take his first full breath of air at age 64.

Regenerative medicine is an extraordinary step in the evolution of mankind, says Jorge Bacardi. It is for Leslie and I a great honor to be able to join Mayo Clinic in the development of such an advancement in the medical field."

Regenerative medicine is addressing the root causes of disease and disability by developing ways to rejuvenate the body using its natural self-healing processes; replace damaged cells with healthy ones derived from the patient (avoiding immune system rejection); and regenerate function by applying specific cells or cell products.

Mayos regenerative medicine researchers are targeting conditions throughout the body, including heart disease, stroke, Alzheimers disease and traumatic injuries that affect combat veterans. Some studies are in the earliest stages. Others are in clinical trials with patients.

Researchers now can differentiate stem cells into skin, brain, lung and many other types of cells. For example, a patient's own skin cells may be collected, reprogrammed in a laboratory to give them certain characteristics, and then delivered back to the patient to treat diseases at various places within the body.

Read the original:
Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

Brisbane mother dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Read more:
Brisbane mother dies in Russia

Queensland mum dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Go here to see the original:
Queensland mum dies in Russia

Qld mum dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Read the original post:
Qld mum dies in Russia

Stem cell treatment warnings

By Stem Cell Doctors

Video will begin in 5 seconds.

While stem cells have many applications in treating bone tumors and early leukaemia and lymphoma cases Dr Tony Bartone says patients undergoing unproven treatments are taking "life into a Tatts Lotto" situation.

Authorities are warning of the risks of unproven stem cell treatments available in Australia and overseas after the death of an Australian woman in Russia.

Brisbane mother-of-two Kellie van Meurs travelled to Moscow for treatment for a rare neurological disorder called Stiff Person Syndrome but died from a heart attack while undergoing the controversial treatment on July 19.

Her death - and the continued marketing of stem cell tourism by groups including Adult Stem Cell Foundation - prompted warnings that manyof the therapies on offer are untested and not acceptedby mainstream science.

Stem Cells Australia's head of education, ethics, law and community awareness Megan Munsie said a proliferation of private clinics combined with a growing consumer base was a potentially dangerous mix.

Advertisement

''This sad case illustrates that some people are prepared to take the risk,'' she said. ''But people should balance their high hopes with the acknowledgement that there is a risk.''

She also cautioned that treatment decisions should be based more on the advice of medical professionals than the experiences outlined in social media, which was flush with success stories and often failed to reflect reality.

In December the country's main medical research funding body, the National Health and Medical Research Council, released a guide for patients and doctors highlighting the risks associated with unproven stem cell treatments in Australia and overseas.

Read more from the original source:
Stem cell treatment warnings

→←